Commerzbank AG (London Branch) - Pre Stabilisation - Fresenius Medical Care AG EUR500mil 5 year
PR Newswire
LONDON, United Kingdom, November 17
Pre-Stabilisation Notice
November 17, 2025
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Fresenius Medical Care AG
EUR 500mil Fixed Rate Notes due 24 November 2030
Launched pursuant to the Issuer's Debt Issuance Programme
Commerzbank AG (contact: Ian Turner; telephone: +44-207-7475-1817) hereby announces, as Stabilisation Coordinator, that the Stabilising Managers named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU Regulation 596/2014).
The security to be stabilised: | |
Issuer: | Fresenius Medical Care AG |
Guarantor (if any): | none |
Aggregate nominal amount: | EUR 500mil |
Description: | EUR 500mil Fixed Rate Notes due 24 November 2030 |
Offer price: | tbc |
Other offer terms: | Debt Issuance Programme, denoms 100k/100k, Luxembourg Stock Exchange |
Stabilisation: | |
Stabilisation Coordinator: Stabilising Managers: | Commerzbank AG BofA Securities Europe SA Mizuho Bank Europe N.V. Société Générale SA |
Stabilisation period expected to start on: | November 17, 2025 |
Stabilisation period expected to end on: | no later than 30 days after the proposed issue date of the securities |
Existence, maximum size and conditions of use of over-allotment facility. | The Stabilising Managers may over-allot the securities to the extent permitted in accordance with applicable law. |
Stabilisation trading venue: | Luxembourg Stock Exchange (regulated market) |
In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not for distribution, directly or indirectly, in or into the United States or any other jurisdiction in which such distribution would be unlawful.
END
